American Journal of Neuroradiology 26:618-624, March 2005
© 2005 American Society of Neuroradiology
BRAIN
Diagnostic and Prognostic Value of Early MR Imaging Vessel Signs in Hyperacute Stroke Patients Imaged <3 Hours and Treated with Recombinant Tissue Plasminogen Activator
a National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD
b Department of Neurology, University of Heidelberg, Heidelberg, Germany
c Department of Neurology, University of Ulsan, Asan Medical Center, Seoul, South Korea
Address correspondence to Peter D. Schellinger, MD, PhD, Department of Neurology, Im Neuenheimer Feld 400, Kopfklinik, D-69120 Heidelberg, Germany
BACKGROUND AND PURPOSE: Analogous to the CT hyperattenuated vessel sign (HMCAS), MR imaging may show hypo- or hyperintense vessels in acute ischemic stroke (AIS) patients. We assessed the diagnostic and prognostic strength of early MR imaging vessel signs in AIS patients treated with intravenous thrombolysis (IVT) within 3 hours of the onset of symptoms.
METHODS: We studied AIS patients both treated with IVT and stroke MR imaged within 3 hours of the onset of symptoms and at 2 hours and 24 hours after treatment. We assessed the presence or absence of early vessel signs (hyperintense fluid-attenuated inversion recovery sign [FLAIR HVS]; gradient-echo susceptibility vessel sign [GRE SVS]) compared with a combined MR angiography/perfusion-weighted imaging reference and their strength for predicting clinical outcome (favorable vs. poor, independent vs. dependent, or dead, death), recanalization (by clot composition and flow), and hemorrhage in uni- and multivariate analysis.
RESULTS: Fifty-six patients (age range, 76 years ± 13 years; median National Institutes of Health stroke scale score [NIHSSS], 11) met the inclusion criteria. Forty-four patients (78.6%) had a vessel occlusion at baseline; 22 of them (50%) recanalized. Nineteen patients (33.9%) suffered some form of intracranial hemorrhage (ICH), 24 patients (42.9%) had an independent outcome, 18 patients (32.1%) a favorable outcome, and 14 patients died. Compared with our combined reference for vessel status PWI/MRA, the sensitivities of CT HMCAS, FLAIR HVS, and GRE SVS were 40%, 66%, and 34%, respectively, and improved during the hours that followed. Localization was accurately reflected by FLAIR HVS but not by GRE SVS. Only NIHSSS and age were independent predictors for recanalization and all clinical outcomes in multiple logistic regression analysis.
CONCLUSION: Although early vessel signs can be helpful in the diagnosis of intravascular disease, they do not independently predict recanalization, ICH, or any of the three clinical outcomes in a multivariate logistic regression model. Thrombus composition as reflected by signal intensity characteristics on GRE and FLAIR does not predict the therapeutic effect of IVT.
This article has been cited by other articles:
![]() |
K. Kimura, Y. Iguchi, K. Shibazaki, M. Watanabe, T. Iwanaga, and J. Aoki M1 Susceptibility Vessel Sign on T2* as a Strong Predictor for No Early Recanalization After IV-t-PA in Acute Ischemic Stroke Stroke, September 1, 2009; 40(9): 3130 - 3132. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kaya, A. Dincer, M.E. Yildiz, M.O. Cizmeli, and C. Erzen Acute Ischemic Infarction Defined by a Region of Multiple Hypointense Vessels on Gradient-Echo T2* MR Imaging at 3T AJNR Am. J. Neuroradiol., June 1, 2009; 30(6): 1227 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Meseguer, M. Mazighi, J. Labreuche, C. Arnaiz, L. Cabrejo, T. Slaoui, C. Guidoux, J.-M. Olivot, H. Abboud, B. Lapergue, et al. Outcomes of Intravenous Recombinant Tissue Plasminogen Activator Therapy According to Gender: A Clinical Registry Study and Systematic Review Stroke, June 1, 2009; 40(6): 2104 - 2110. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Lee, L. L. Latour, M. Luby, A. W. Hsia, J. G. Merino, and S. Warach Distal hyperintense vessels on FLAIR: An MRI marker for collateral circulation in acute stroke? Neurology, March 31, 2009; 72(13): 1134 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sanossian, J.L. Saver, J.R. Alger, D. Kim, G.R. Duckwiler, R. Jahan, F. Vinuela, B. Ovbiagele, and D.S. Liebeskind Angiography Reveals That Fluid-Attenuated Inversion Recovery Vascular Hyperintensities Are Due to Slow Flow, Not Thrombus AJNR Am. J. Neuroradiol., March 1, 2009; 30(3): 564 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Doufekias, A. Z. Segal, and J. R. Kizer Cardiogenic and aortogenic brain embolism. J. Am. Coll. Cardiol., March 18, 2008; 51(11): 1049 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zangerle, S. Kiechl, M. Spiegel, M. Furtner, M. Knoflach, P. Werner, A. Mair, G. Wille, C. Schmidauer, K. Gautsch, et al. Recanalization after thrombolysis in stroke patients: Predictors and prognostic implications Neurology, January 2, 2007; 68(1): 39 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Srinivasan, M. Goyal, F. A. Azri, and C. Lum State-of-the-Art Imaging of Acute Stroke1 RadioGraphics, October 1, 2006; 26(suppl_1): S75 - S95. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ribo, J. Alvarez-Sabin, J. Montaner, F. Romero, P. Delgado, M. Rubiera, R. Delgado-Mederos, and C. A. Molina Temporal Profile of Recanalization After Intravenous Tissue Plasminogen Activator: Selecting Patients for Rescue Reperfusion Techniques Stroke, April 1, 2006; 37(4): 1000 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Molina Imaging the Clot: Does Clot Appearance Predict the Efficacy of Thrombolysis? Stroke, November 1, 2005; 36(11): 2333 - 2334. [Full Text] [PDF] |
||||
![]() |
K.-H. Cho, J. S. Kim, S. U. Kwon, A-H. Cho, and D.-W. Kang Significance of Susceptibility Vessel Sign on T2*-Weighted Gradient Echo Imaging for Identification of Stroke Subtypes Stroke, November 1, 2005; 36(11): 2379 - 2383. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Liebeskind Location, Location, Location: Angiography Discerns Early MR Imaging Vessel Signs Due to Proximal Arterial Occlusion and Distal Collateral Flow AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2432 - 2433. [Full Text] [PDF] |
||||
![]() |
P. D. Schellinger and S. Warach Reply AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2433 - 2434. [Full Text] [PDF] |
||||




